MA
Therapeutic Areas
Immunosys Pipeline
| Drug | Indication | Phase |
|---|---|---|
| COMPIT Project | Drug-Induced Tissue Damage (Immunological Risk Assessment) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| COMPIT Project | Drug-Induced Tissue Damage (Immunological Risk Assessment) | Preclinical |